Muscarinic <scp> M <sub>3</sub> </scp> positive allosteric modulator <scp>ASP8302</scp> enhances bladder contraction and improves voiding dysfunction in rats-Reference-Cited by-同舟云学术

Muscarinic M ₃ positive allosteric modulator ASP8302 enhances bladder contraction and improves voiding dysfunction in rats

Published:2022-02-12 Issue:4 Volume:14 Page:289-300
ISSN:1757-5664
Container-title:LUTS: Lower Urinary Tract Symptoms
language:en
Short-container-title:LUTS

Author:

Okimoto Risa¹^ORCID,Ino Katsutoshi¹,Ishizu Kenichiro¹,Takamatsu Hajime¹,Sakamoto Kazuyuki¹^ORCID,Yuyama Hironori¹,Imazumi Katsunori¹,Ohtake Akiyoshi¹,Masuda Noriyuki¹,Takeda Masahiro¹

Affiliation:

1. Drug Discovery Research Astellas Pharma Inc Ibaraki Japan

Funder

Astellas Pharma

Publisher

Wiley

Subject

Urology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/luts.12430

Reference39 articles.

1. The neural control of micturition

2. Detrusor Underactivity and the Underactive Bladder: A New Clinical Entity? A Review of Current Terminology, Definitions, Epidemiology, Aetiology, and Diagnosis

3. Detrusor underactivity: a plea for new approaches to a common bladder dysfunction;Koeveringe GA;NeurourolUrodyn,2011

4. Terminology report from the international continence society (ICS) working group on underactive bladder (UAB);Chapple CR;NeurourolUrodyn,2018

5. Muscarinic Agonists and Antagonists: Effects on the Urinary Bladder

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Muscarinic M₃ Receptor‐Positive Allosteric Modulator ASP8302 Following Single and Multiple Ascending Oral Doses in Healthy Volunteers;Clinical Pharmacology in Drug Development;2024-08-09